Although the implications of METTL1 in hepatoblastoma carcinogenesis have not been reported, two new publications showed that METTL1 is related to radiotherapy resistance [36] and recurrence post-radiofrequency ablation [37] in hepatocellular carcinoma. The gene discussed is METTL1; the disease is hepatoblastoma.